New CMS Demo Aims to Increase Access to GLP-1s Under Medicaid and Part D
https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(MedPage Today) — The Trump administration announced a new demonstration program aimed at making GLP-1 receptor agonists more accessible to enrollees in Medicare Part D and Medicaid plans, but experts say it’s unclear how popular or effective it will be…
